NCT00501202View on ClinicalTrials.gov

Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).

PHASE2CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Diabetic Neuropathy, PainfulDiabetic NeuralgiaDiabetic PolyneuropathyDiabetic Mononeuropathy
Interventions
DRUG

placebo

twice daily for 4 weeks

DRUG

RWJ-333369 (carisbamate)

200 mg tablet twice daily for 4 weeks

All Listed Sponsors
lead

SK Life Science, Inc.

INDUSTRY

NCT00501202 - Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN). | Biotech Hunter | Biotech Hunter